Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The bill stops Medicare from using competitive acquisition for urological and ostomy supplies for five years (2028‑2033). It creates a technical expert panel and a limited‑scope demonstration project to evaluate whether such supplies should later be included. It also bans suppliers from pressuring patients to switch brands and guarantees patients the right to obtain the same or clinically comparable products.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get an email when HR 10787 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10787 freeOr ask your AI assistant about HR 10787 directly:
Add to Claude, ChatGPT or Cursor